One can prefer Dr Reddys Laboratories, Sun Pharma over Ranbaxy, says Suresh Mahadevan, MD & Head of Indian Equities at UBS Securities.
first published: May 14, 2013 03:54 pm
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.